Page last updated: 2024-10-25

citalopram and Amentia

citalopram has been researched along with Amentia in 36 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"To assess efficacy and safety of citalopram compared to quetiapine and olanzapine for the treatment of agitation in patients with Alzheimer disease (AD)."9.24Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia. ( Chiriac, IM; Ettorre, E; Viscogliosi, G, 2017)
"The aim was to determine the relationship between (R) and (S)-citalopram enantiomer exposure (AUC(0,24 h)) and therapeutic response in agitated individuals greater than 60 years old with Alzheimer's dementia (AD)."9.22R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. ( Bies, R; Devanand, DP; Drye, LT; Ho, T; Lyketsos, C; Mintzer, JE; Mulsant, BH; Munro, CA; Pollock, BG; Porsteinsson, AP; Schantz, O; Schneider, LS; Shade, DM; Weintraub, D; Yesavage, J, 2016)
"This study examined the potential of an antidepressant drug, escitalopram, to improve depression, resilience to stress, and quality of life in family dementia caregivers in a randomized placebo-controlled double-blinded trial."9.14Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram. ( Irwin, MR; Lavretsky, H; Siddarth, P, 2010)
"To compare citalopram and risperidone for the treatment of psychotic symptoms and agitation associated with dementia, with a priori hypotheses that risperidone would be more efficacious for psychosis and citalopram for agitation."9.12A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. ( Blakesley, RE; Houck, PR; Huber, KA; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, J, 2007)
" This randomised, double-blind study compared the efficacy and tolerability of citalopram and mianserin in 336 elderly, depressed patients with or without dementia."9.09A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. ( Augusto De Mendonça Lima, C; Eglin, M; Godderis, J; Karlsson, I; Nygaard, H; Simányi, M; Taal, M, 2000)
"A total of 149 patients in 7 centers in Denmark, Norway and Sweden entered a 6-week double-blind trial intended to assess the antidepressant effect and safety of citalopram vs placebo in depressed elderly patients (65 years of age or older) who might also suffer from somatic disorders and/or senile dementia."9.07A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. ( Eriksson, S; Gottfries, CG; Gylding-Sabroe, J; Kristensen, M; Lyby, K; Nyth, AL; Ofsti, E; Refsum, HE; Smedegaard-Andersen, L; Syversen, S, 1992)
" This report describes a patient with PDD who developed deep venous thrombosis (DVT) and hyponatremia after initiating citalopram treatment."8.31Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report. ( Albalawi, A, 2023)
"to compare different doses of escitalopram (cipralex) in the prevention of dementia in patients with depression and moderate cognitive dysfunction associated with chronic brain ischemia."7.81[Comparison of different doses of escitalopram in the prevention of dementia in patients with depression and moderate cognitive dysfunction associated with chronic brain ischemia]. ( Zhitkova, JV, 2015)
"To assess efficacy and safety of citalopram compared to quetiapine and olanzapine for the treatment of agitation in patients with Alzheimer disease (AD)."5.24Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia. ( Chiriac, IM; Ettorre, E; Viscogliosi, G, 2017)
"The aim was to determine the relationship between (R) and (S)-citalopram enantiomer exposure (AUC(0,24 h)) and therapeutic response in agitated individuals greater than 60 years old with Alzheimer's dementia (AD)."5.22R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. ( Bies, R; Devanand, DP; Drye, LT; Ho, T; Lyketsos, C; Mintzer, JE; Mulsant, BH; Munro, CA; Pollock, BG; Porsteinsson, AP; Schantz, O; Schneider, LS; Shade, DM; Weintraub, D; Yesavage, J, 2016)
"This study examined the potential of an antidepressant drug, escitalopram, to improve depression, resilience to stress, and quality of life in family dementia caregivers in a randomized placebo-controlled double-blinded trial."5.14Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram. ( Irwin, MR; Lavretsky, H; Siddarth, P, 2010)
"To compare citalopram and risperidone for the treatment of psychotic symptoms and agitation associated with dementia, with a priori hypotheses that risperidone would be more efficacious for psychosis and citalopram for agitation."5.12A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. ( Blakesley, RE; Houck, PR; Huber, KA; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, J, 2007)
" This randomised, double-blind study compared the efficacy and tolerability of citalopram and mianserin in 336 elderly, depressed patients with or without dementia."5.09A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. ( Augusto De Mendonça Lima, C; Eglin, M; Godderis, J; Karlsson, I; Nygaard, H; Simányi, M; Taal, M, 2000)
"A total of 149 patients in 7 centers in Denmark, Norway and Sweden entered a 6-week double-blind trial intended to assess the antidepressant effect and safety of citalopram vs placebo in depressed elderly patients (65 years of age or older) who might also suffer from somatic disorders and/or senile dementia."5.07A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. ( Eriksson, S; Gottfries, CG; Gylding-Sabroe, J; Kristensen, M; Lyby, K; Nyth, AL; Ofsti, E; Refsum, HE; Smedegaard-Andersen, L; Syversen, S, 1992)
"Randomized, controlled trials of antidepressants (selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, trazodone, and other antidepressants), compared to either placebo or comparator medications (typical or atypical antipsychotics, anticonvulsants, benzodiazepines, cholinesterase inhibitors, memantine or other medications) for treatment of agitation or psychosis in older adults with dementia."4.87Antidepressants for agitation and psychosis in dementia. ( Adunuri, N; Gill, SS; Gruneir, A; Herrmann, N; Rochon, P; Seitz, DP, 2011)
" This report describes a patient with PDD who developed deep venous thrombosis (DVT) and hyponatremia after initiating citalopram treatment."4.31Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report. ( Albalawi, A, 2023)
"Long-term treatment with tricyclic antidepressants, Hypericum perforatum, or escitalopram may be associated with reduced incidence of dementia."3.96To Be Continued? Long-Term Treatment Effects of Antidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia: A German Case-Control Study. ( Bartels, C; Belz, M; Bohlken, J; Hessmann, P; Kostev, K; Vogelgsang, J; Wiltfang, J, 2020)
"to compare different doses of escitalopram (cipralex) in the prevention of dementia in patients with depression and moderate cognitive dysfunction associated with chronic brain ischemia."3.81[Comparison of different doses of escitalopram in the prevention of dementia in patients with depression and moderate cognitive dysfunction associated with chronic brain ischemia]. ( Zhitkova, JV, 2015)
"An open, multi-centre study was designed to address the effectiveness and tolerability profile of treatment with escitalopram under naturalistic conditions, in elderly outpatients (above 65 years of age) with depression."3.76Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany. ( Flürenbrock, W; Möller, HJ; Schnitker, J, 2010)
" Dosing strategies, discontinuation considerations, and side effects are discussed."2.72The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. ( Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN, 2021)
"Citalopram was found to be more efficacious than placebo in the short-term hospital treatment of psychotic symptoms and behavioral disturbances in nondepressed, demented patients."2.70Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. ( Bharucha, A; Chew, ML; Huber, KA; Jacob, NJ; Kastango, KB; Marin, R; Mazumdar, S; Mulsant, BH; Pollock, BG; Rosen, J; Sweet, RA, 2002)
"Citalopram is a selective serotonin re-uptake inhibitor that has demonstrated antidepressant efficacy in numerous controlled clinical trials."2.41Citalopram: a comprehensive review. ( Pollock, BG, 2001)
"Depression is a highly prevalent concomitant of dementia."2.40Depression and dementia: comorbidities, identification, and treatment. ( Meyers, BS, 1998)
"Citalopram is an SSRI drug with an attractive pharmacokinetic profile, i."2.39Scandinavian experience with citalopram in the elderly. ( Gottfries, CG, 1996)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (22.22)18.2507
2000's7 (19.44)29.6817
2010's16 (44.44)24.3611
2020's5 (13.89)2.80

Authors

AuthorsStudies
Bucki, A1
Marcinkowska, M1
Śniecikowska, J1
Więckowski, K1
Pawłowski, M1
Głuch-Lutwin, M1
Gryboś, A1
Siwek, A1
Pytka, K1
Jastrzębska-Więsek, M1
Partyka, A1
Wesołowska, A1
Mierzejewski, P1
Kołaczkowski, M1
Fischer, CE3
Namasivayam, A3
Crawford-Holland, L3
Hakobyan, N3
Schweizer, TA3
Munoz, DG3
Pollock, BG11
Albalawi, A1
Bartels, C1
Belz, M1
Vogelgsang, J1
Hessmann, P1
Bohlken, J1
Wiltfang, J1
Kostev, K1
Chen, A1
Copeli, F1
Metzger, E1
Cloutier, A1
Osser, DN1
Smith, GS1
Kuwabara, H1
Nandi, A1
Gould, NF1
Nassery, N1
Savonenko, A1
Joo, JH1
Kraut, M1
Brasic, J1
Holt, DP1
Hall, AW1
Mathews, WB1
Dannals, RF1
Avramopoulos, D1
Workman, CI1
Viscogliosi, G1
Chiriac, IM1
Ettorre, E1
Rubin, R1
Koenig, AM1
Butters, MA1
Begley, A1
Ogbagaber, S1
Wahed, AS1
Reynolds, CF1
Kotbi, N1
Singh, A1
Kneifati-Hayek, J1
Odom, A1
Alexopoulos, G1
Zhitkova, JV1
Wilkins, JM1
Forester, BP1
Ho, T1
Mulsant, BH6
Schantz, O1
Devanand, DP1
Mintzer, JE1
Porsteinsson, AP1
Schneider, LS1
Weintraub, D1
Yesavage, J1
Drye, LT1
Munro, CA1
Shade, DM1
Lyketsos, C1
Bies, R1
Ozturk, A1
Yasar, H1
Gulsun, M1
Balıkcı, A1
Bozoglu, E1
Naharcı, MI1
Boyraz, O1
Oztın, H1
Doruk, H1
Dombrovski, AY1
Ferrell, RE1
Lotrich, FE1
Rosen, JI1
Wallace, M1
Houck, PR3
Mazumdar, S4
Lavretsky, H1
Siddarth, P1
Irwin, MR1
Möller, HJ1
Schnitker, J1
Flürenbrock, W1
Seitz, DP1
Adunuri, N1
Gill, SS1
Gruneir, A1
Herrmann, N1
Rochon, P1
Tremolizzo, L1
Fermi, S1
Fusco, ML1
Susani, E1
Frigo, M1
Piolti, R1
Ferrarese, C1
Appollonio, I1
Ismail, Z1
Emeremni, CA1
Rosen, J3
Rajji, TK1
Schölzel-Dorenbos, CJ1
Blakesley, RE1
Huber, KA2
Leblhuber, F1
Gottfries, CG4
Ragneskog, H1
Eriksson, S3
Karlsson, I3
Soares, JC1
Gershon, S1
Meyers, BS1
Godderis, J1
Augusto De Mendonça Lima, C1
Nygaard, H1
Simányi, M1
Taal, M1
Eglin, M1
Kim, KY1
Bader, GM1
Jones, E1
Spigset, O1
Wilhelmsson, C1
Mjörndal, T1
Sweet, RA1
Bharucha, A1
Marin, R1
Jacob, NJ1
Kastango, KB1
Chew, ML1
Nyth, AL2
Lyby, K1
Smedegaard-Andersen, L1
Gylding-Sabroe, J1
Kristensen, M1
Refsum, HE1
Ofsti, E1
Syversen, S1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Caring for Caregivers With Mind-body Exercise[NCT04019301]47 participants (Actual)Interventional2019-04-22Active, not recruiting
Post Marketing Study of Escitalopram Versus Risperidone for the Treatment of Behavioral and Psychological Symptoms Amongst Alzheimer's Disease Patients[NCT01119638]Phase 440 participants (Actual)Interventional2008-04-30Completed
Study to Determine Steady-state Level of Citalopram Pharmacokinetic Parameters in Patients With Short Bowel Syndrome[NCT00876226]0 participants (Actual)Interventional2010-05-01Withdrawn
Continuation Pharmacotherapy for Agitation of Dementia[NCT00073658]Phase 2137 participants Interventional2000-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for citalopram and Amentia

ArticleYear
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment.
    The Psychiatric clinics of North America, 2022, Volume: 45, Issue:4

    Topics: Aged; Antipsychotic Agents; Citalopram; Dementia; Humans; Psychotic Disorders; Schizophrenia

2022
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
    Psychiatry research, 2021, Volume: 295

    Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazol

2021
Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
    Current psychiatry reports, 2016, Volume: 18, Issue:2

    Topics: Antipsychotic Agents; Caregivers; Citalopram; Dementia; Humans; Psychomotor Agitation; Psychotic Dis

2016
Antidepressants for agitation and psychosis in dementia.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Adult; Antidepressive Agents; Citalopram; Dementia; Humans; Psychomotor Agitation; Psychotic Disorde

2011
Scandinavian experience with citalopram in the elderly.
    International clinical psychopharmacology, 1996, Volume: 11 Suppl 1

    Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Dementia; Depressive Disorder; Dopamine; Human

1996
Therapeutic targets in late-life psychoses: review of concepts and critical issues.
    Schizophrenia research, 1997, Oct-30, Volume: 27, Issue:2-3

    Topics: Affective Disorders, Psychotic; Age Factors; Age of Onset; Aged; Antipsychotic Agents; Benzodiazepin

1997
Depression and dementia: comorbidities, identification, and treatment.
    Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cog

1998
Behavioral disturbances of dementia.
    Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4

    Topics: Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Behavioral S

1998
Citalopram: a comprehensive review.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4

    Topics: Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Clinical Trials

2001
Treatment of depression in elderly patients with and without dementia disorders.
    International clinical psychopharmacology, 1992, Volume: 6 Suppl 5

    Topics: Aged; Alzheimer Disease; Citalopram; Dementia; Dementia, Vascular; Depressive Disorder; Humans; Neur

1992

Trials

11 trials available for citalopram and Amentia

ArticleYear
Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.
    Journal of the American Medical Directors Association, 2017, Sep-01, Volume: 18, Issue:9

    Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Citalopram;

2017
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
    British journal of clinical pharmacology, 2016, Volume: 82, Issue:3

    Topics: Aged; Alzheimer Disease; Citalopram; Dementia; Female; Humans; Isomerism; Male; Psychiatric Status R

2016
Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    International clinical psychopharmacology, 2010, Volume: 25, Issue:1

    Topics: Aged; Aged, 80 and over; Alleles; Antipsychotic Agents; Behavioral Symptoms; Citalopram; Dementia; F

2010
Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2010, Volume: 18, Issue:2

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Caregivers; Citalopram;

2010
A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2013, Volume: 21, Issue:1

    Topics: Aged, 80 and over; Citalopram; Dementia; Double-Blind Method; Female; Humans; Male; Psychiatric Stat

2013
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11

    Topics: Aged, 80 and over; Antipsychotic Agents; Citalopram; Dementia; Double-Blind Method; Female; Hospital

2007
[Citalopram in treatment of behavioral disorders in demented patients].
    Acta medica Austriaca, 1994, Volume: 21, Issue:4

    Topics: Affective Symptoms; Aged; Aged, 80 and over; Alzheimer Disease; Citalopram; Dementia; Double-Blind M

1994
A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    International journal of geriatric psychiatry, 2000, Volume: 15, Issue:4

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Citalopram; Dementia; Depressive

2000
Low serum sodium concentrations during treatment with citalopram in elderly patients: relationship to serum citalopram levels and to platelet serotonin 5-HT2A receptor status.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5

    Topics: Aged; Aged, 80 and over; Blood Platelets; Citalopram; Dementia; Electrolytes; Female; Humans; Male;

2000
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.
    The American journal of psychiatry, 2002, Volume: 159, Issue:3

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Behavioral Symptoms; Citalopram; Dementia; Donepezil;

2002
A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.
    Acta psychiatrica Scandinavica, 1992, Volume: 86, Issue:2

    Topics: Aged; Citalopram; Cognition; Dementia; Depressive Disorder; Double-Blind Method; Humans; Placebos

1992

Other Studies

15 other studies available for citalopram and Amentia

ArticleYear
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Affect; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Dementia; Dopamine Agonist

2017
Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.
    BMC geriatrics, 2023, 06-01, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Behavioral Symptoms; Citalopram; Dementia; Female; Humans; Hyponatremia; Pa

2023
To Be Continued? Long-Term Treatment Effects of Antidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia: A German Case-Control Study.
    The Journal of clinical psychiatry, 2020, 08-25, Volume: 81, Issue:5

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studi

2020
Molecular imaging of beta-amyloid deposition in late-life depression.
    Neurobiology of aging, 2021, Volume: 101

    Topics: Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Antidepressive Agents, Second-Generatio

2021
Exploring the Relationship Between Depression and Dementia.
    JAMA, 2018, Sep-11, Volume: 320, Issue:10

    Topics: Adult; Aged, 80 and over; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Dementia; Depres

2018
Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2019, Volume: 27, Issue:10

    Topics: Alzheimer Disease; Anxiety; Citalopram; Dementia; Humans; Psychomotor Agitation

2019
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysf

2014
Citalopram in agitated and delusional demented patients who failed treatment with antipsychotic agents.
    The Journal of neuropsychiatry and clinical neurosciences, 2014, Apr-01, Volume: 26, Issue:2

    Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Citalopram; Delus

2014
[Comparison of different doses of escitalopram in the prevention of dementia in patients with depression and moderate cognitive dysfunction associated with chronic brain ischemia].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:8

    Topics: Aged; Antidepressive Agents, Second-Generation; Brain Ischemia; Chronic Disease; Citalopram; Cogniti

2015
Remission in visual hallucinatory experiences after citalopram treatment in a patient with dementia.
    Geriatrics & gerontology international, 2017, Volume: 17, Issue:2

    Topics: Citalopram; Dementia; Hallucinations; Humans; Remission Induction

2017
Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.
    Pharmacopsychiatry, 2010, Volume: 43, Issue:6

    Topics: Aged; Aged, 80 and over; Bipolar Disorder; Citalopram; Dementia; Depression; Depressive Disorder; De

2010
Generalized action myoclonus associated with escitalopram in a patient with mixed dementia.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3

    Topics: Aged; Citalopram; Dementia; Depression; Female; Humans; Myoclonus

2011
Mild behavioral impairment: a prodromal stage of frontotemporal lobar degeneration.
    Journal of the American Geriatrics Society, 2006, Volume: 54, Issue:1

    Topics: Brain; Citalopram; Dementia; Diagnosis, Differential; Humans; Male; Middle Aged; Neuropsychological

2006
Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram.
    International psychogeriatrics, 1996,Winter, Volume: 8, Issue:4

    Topics: Affective Symptoms; Aged; Alzheimer Disease; Antidepressive Agents; Anxiety Disorders; Citalopram; C

1996
Citalopram for verbal agitation in patients with dementia.
    Journal of geriatric psychiatry and neurology, 2000,Summer, Volume: 13, Issue:2

    Topics: Citalopram; Dementia; Humans; Long-Term Care; Male; Middle Aged; Psychomotor Agitation; Selective Se

2000